Precision BioSciences, Inc.

NasdaqCM:DTIL Stock Report

Market Cap: US$41.8m

Precision BioSciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:DTIL Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
30 Dec 24BuyUS$16,186Geno GermanoIndividual3,605US$4.49
27 Dec 24BuyUS$21,082Kevin BuehlerIndividual4,320US$4.88
27 Dec 24BuyUS$10,037John KellyIndividual2,113US$4.75
26 Dec 24BuyUS$13,723Melinda BrownIndividual3,016US$4.55
21 Nov 24BuyUS$20,280John KellyIndividual3,000US$6.76
08 May 24BuyUS$100,008John KellyIndividual8,334US$12.00
08 May 24BuyUS$9,996Dario ScimecaIndividual833US$12.00
08 May 24BuyUS$9,996Jefferson SmithIndividual833US$12.00
08 May 24BuyUS$100,008Michael AmorosoIndividual8,334US$12.00

Insider Trading Volume

Insider Buying: DTIL insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of DTIL?
Owner TypeNumber of SharesOwnership Percentage
Public Companies413,5815.39%
Individual Insiders750,4499.78%
Hedge Funds942,62612.3%
General Public2,157,99728.1%
Institutions3,406,40644.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 16.9%.

Top Shareholders

Top 25 shareholders own 67.76% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.99%
Lynx1 Capital Management LP
766,051US$4.2m0%1.46%
8.78%
Tang Capital Management, LLC
673,332US$3.7m8.02%0.2%
6.99%
Aquilo Capital Management, LLC
536,376US$2.9m40.5%5.37%
5.39%
Novartis AG
413,581US$2.3m0%no data
5.3%
Highbridge Capital Management, LLC
406,250US$2.2m0%0.26%
5.16%
Benjamin Weinstein
395,489US$2.2m0%no data
3.94%
Goldman Sachs Group, Investment Banking and Securities Investments
302,168US$1.6m1,750%no data
3.63%
The Vanguard Group, Inc.
278,222US$1.5m5.4%no data
3.24%
Acadian Asset Management LLC
248,620US$1.4m65.6%no data
2%
Citadel Advisors LLC
153,675US$837.5k58%no data
1.43%
Renaissance Technologies LLC
109,798US$598.4k36.2%no data
1.4%
Michael Amoroso
107,087US$583.6k275%no data
1.3%
Alyeska Investment Group, L.P.
100,000US$545.0k-43.3%no data
1.25%
Jefferson Smith
95,736US$521.8k25.2%no data
1.14%
Moloney Securities Asset Management LLC
87,799US$478.5k177%0.06%
1.12%
John Kelly
86,256US$470.1k115%no data
0.89%
UBS Asset Management AG
68,615US$374.0k3,540%no data
0.84%
Geode Capital Management, LLC
64,541US$351.7k-2.17%no data
0.72%
Dimensional Fund Advisors LP
55,475US$302.3k0%no data
0.72%
BlackRock, Inc.
55,122US$300.4k0.02%no data
0.61%
Squarepoint OPS LLC
46,929US$255.8k0%no data
0.52%
RBC Global Asset Management Inc.
40,000US$218.0k0%no data
0.5%
Jane Street Group, LLC, Asset Management Arm
38,364US$209.1k0%no data
0.48%
Northern Trust Global Investments
37,076US$202.1k-0.63%no data
0.41%
Jacob Asset Management of New York LLC
31,646US$172.5k0%0.21%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/23 18:35
End of Day Share Price 2025/03/21 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Precision BioSciences, Inc. is covered by 9 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Konstantinos BiliourisBMO Capital Markets Equity Research
Debjit ChattopadhyayGuggenheim Securities, LLC
Patrick TrucchioH.C. Wainwright & Co.